Marcianò Gianmarco, Caroleo Benedetto, Catarisano Luca, Cocchis Donatella, Palleria Caterina, De Sarro Giovambattista, Gallelli Luca
Operative Unit of Pharmacology and Pharmacovigilance, "Renato Dulbecco" University Hospital, 88100 Catanzaro, Italy.
Operative Unit of Internal Medicine, Soverato Hospital, ASP7 Catanzaro, 88100 Catanzaro, Italy.
Reports (MDPI). 2024 May 6;7(2):33. doi: 10.3390/reports7020033.
Liver transplant patients are frail subjects due to lifelong therapy with immunosuppressants. In these patients, comorbidity and polytherapy increase the risk of adverse drug reactions. In this study, we report the development of hyponatremia, probably related to pantoprazole in a liver transplant patient. Sertraline dismission and treatment with sodium chloride did not improve clinical symptoms and laboratory levels. Pantoprazole dismission induced an improvement in clinical symptoms and the normalization of sodium levels. A five-month follow-up revealed the absence of clinical symptoms and normal serum sodium levels.
由于需要终身使用免疫抑制剂进行治疗,肝移植患者身体较为虚弱。在这些患者中,合并症和联合治疗增加了药物不良反应的风险。在本研究中,我们报告了一名肝移植患者发生低钠血症,可能与泮托拉唑有关。停用舍曲林并使用氯化钠治疗并未改善临床症状和实验室指标。停用泮托拉唑后临床症状有所改善,钠水平恢复正常。五个月的随访显示无临床症状,血清钠水平正常。